Company / Current Liabilities
Eton Pharmaceuticals, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$38.5M
FY2025
5-year range
$4.6M / $38.5M
FY2021-FY2025
Trend
+93.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 6 consecutive years, from $2M in FY2019 to $38M in FY2025.
Based on SEC 10-K filings.
$38M in FY2025 with a 5-year CAGR of +58.9%.
Increased from $16M to $38M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +81.3%
- 5-Year CAGR
- +58.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Eton Pharmaceuticals, Inc.'s current liabilities has grown for 6 consecutive years.
- 5-year CAGR of +58.9%, indicating consistent growth.
- In FY2025, current liabilities increased 93.0% year-over-year.
- Lowest current liabilities in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.5M | +93.0% |
| FY2024 | $19.9M | +22.8% |
| FY2023 | $16.2M | +151.4% |
| FY2022 | $6.5M | +41.8% |
| FY2021 | $4.6M | +20.1% |
| FY2020 | $3.8M | +93.3% |
| FY2019 | $2.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026